Fig. 4From: A scoping review and proposed workflow for multi-omic rare disease researchMulti-omic studies of rare disease are primarily conducted on rare cancers (64%, 42 studies). Two studies of pre-cancerous disorders were included (3%), and the remaining 22 studies (33%) were of non-cancerous rare diseasesBack to article page